CALC
CalciMedica Inc.
$0.58
+$0.00(+0.78%)
22
Overall
40
Value
10
Tech
18
Quality
Market Cap
$9.78M
Volume
29.24K
52W Range
$0.46 - $7.20
Target Price
$10.33
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||||
| Operating Expenses | $29.8M | $35.9M | $14.2M | $38.1M | $24.2M | ||
| Research & Development | $21.0M | $18.9M | $8.3M | $15.9M | $14.5M | ||
| Research Expense | $21.0M | $18.9M | $8.3M | $15.9M | $14.5M | ||
| Selling, General & Administrative | $16.1M | $17.0M | $5.8M | $22.2M | $9.7M | ||
| Selling & Marketing Expenses | $7.2M | -- | -- | -- | -- | ||
| General & Administrative Expenses | $8.9M | $17.0M | $5.8M | $22.2M | $9.7M | ||
| Salaries & Wages | -- | -- | $1.8M | $12.0M | -- | ||
| Depreciation & Amortization | $395.0K | $500.0K | $52.0K | $58.0K | $58.0K | ||
| Depreciation & Amortization | $395.0K | $500.0K | $52.0K | $58.0K | -- | ||
| Other Operating Expenses | $-406.0K | $-257.0K | $-973.0K | $-2.8M | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-29.8M | $-35.9M | $-14.2M | $-38.1M | $-24.2M | ||
| EBITDA | $-36.5M | $-35.3M | $-9.0M | $-34.3M | $-13.6M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | -- | -- | $132.0K | -- | -- | ||
| Intinc | $143.0K | $126.0K | $575.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $143.0K | $126.0K | $132.0K | -- | -- | ||
| Other Income/Expense | $-1.3M | $-732.0K | $6.5M | $-550.0K | $-1.0M | ||
| Other Special Charges | $1.3M | $732.0K | $-28.0K | $550.0K | $1.0M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | -- | $3.0M | $5.7M | -- | ||
| Special Income Charges | -- | -- | $-3.0M | $-5.7M | $-5.7M | ||
| Impairment of Capital Assets | -- | -- | $1.6M | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-36.9M | $-35.8M | $-9.0M | $-34.4M | $-13.7M | ||
| Pre-Tax Income | $-36.9M | $-35.8M | $-7.8M | $-37.5M | $-23.2M | ||
| INCOME TAX | |||||||
| Tax Provision | -- | -- | $-1.3M | $1.0K | -- | ||
| NET INCOME | |||||||
| Net Income | $-27.5M | $-35.8M | $-7.8M | $-34.4M | $-13.7M | ||
| Net Income (Continuing Operations) | $-27.5M | $-35.8M | $-7.8M | $-34.4M | $-13.7M | ||
| Net Income (Discontinued Operations) | $-27.5M | $-35.8M | $-7.8M | $-34.4M | $-13.7M | ||
| Net Income (Common Stockholders) | $-34.7M | $-35.8M | $-9.1M | $-34.4M | $-13.7M | ||
| TOTALS | |||||||
| Total Expenses | $29.8M | $35.9M | $14.2M | $38.1M | $24.2M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $472.7K | $1.5M | $1.5M | $4.5M | $11.2M | ||
| Average Shares Outstanding (Diluted) | $472.7K | -- | $1.5M | $4.5M | $11.2M | ||
| Shares Outstanding | $1.5M | $1.5M | $1.6M | $10.7M | $13.5M | ||
| Basic EPS | $-73.5 | $-23.66 | $-23.24 | $-7.66 | $-1.22 | ||
| Basic EPS (Continuing Operations) | $-73.5 | $-23.66 | $-23.24 | $-7.66 | $-1.22 | ||
| Diluted EPS | $-73.5 | $-23.66 | $-23.24 | $-7.66 | $-1.22 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-23.24 | $-7.66 | $-1.22 | ||
| OTHER METRICS | |||||||
| Accrued Preferred Stock Dividends | $7.2M | -- | -- | -- | -- | ||
| Acquisition Expense | -- | -- | -- | $10.5M | -- | ||
| Marketing Expense | $7.2M | -- | -- | -- | -- | ||
| Net Income From Other Gains Losses | $2.2M | -- | -- | -- | -- | ||
| Other Gand A | $8.9M | $17.0M | $5.8M | $22.2M | $9.7M | ||
| Other Impairment Of Capital Assets | -- | -- | $1.3M | -- | -- | ||
| Otherunder Preferred Stock Dividend | $7.2M | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $7.2M | -- | -- | -- | -- | ||
| Rent And Landing Fees | -- | -- | $221.0K | $274.0K | -- | ||
| Restruct | -- | -- | $3.0M | $5.7M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CALC | $0.58 | +0.8% | 29.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |